The More These Dividend Machines Drop, The More I Buy

Leading blue-chip dividend machines have recently sold off quite aggressively. I detail several reasons why I am very happy about this development. I also share how I am taking advantage of the sell-off, including some of my favorite investments right now.

Seeking Alpha • Sep 25, 2026

Risk-Wary Family Offices Double Down on Infrastructure

Geopolitical shocks have pushed family offices to rethink nearly every corner of their portfolios. Infrastructure has emerged as the asset class they trust most right now.

ETF Trends • Jul 21, 2026

Private Equity Dealmakers Face Reckoning In Washington

A new law set to take effect Friday, July 10, that limits private equity purchases of single-family homes takes aim at a practice blamed for reducing the availability of affordable housing. Under Trump, federal enforcers relaxed oversight of PE firms, declining to single them out for special treatment as state attorneys general sought to restrict their investments, especially in healthcare.

Seeking Alpha • Jul 11, 2026

Pace Of Private Equity Exits Slows In H1 2026

The number of private equity exits slowed during the first half of 2026, as market uncertainty continued to prevent buyers and sellers from finding common ground on valuations. Global private equity and venture capital firms announced 1,504 exits between Jan. 1 and June 30, down 6% from the 1,601 exits recorded in the first half of 2025, according to S&P Global Market Intelligence data.

Seeking Alpha • Jul 9, 2026

Alzprotect Announces FDA Clearance of IND for AZP2006 (Ezeprogind®) in Progressive Supranuclear Palsy (PSP)

LILLE, France--(BUSINESS WIRE)-- #PSP--Alzprotect today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for AZP2006 (Ezeprogind®) for the treatment of Progressive Supranuclear Palsy (PSP). FDA clearance permits the Company to begin clinical development of AZP2006 in the United States. “FDA IND clearance is a pivotal step in our PSP program,” said Philippe Verwaerde, PhD, President & Chief science Officer. “We can now e.

Business Wire • May 28, 2026

Waymo's $16 Billion Round Drives Private Equity Investment Surge In Autonomous Vehicles

Global private equity investment in autonomous vehicles in the first four months of 2026 surged to its highest level in at least 10 years. Between Jan. 1 and April 28, transaction value in the sector totaled $23.26 billion, compared with $10.18 billion in all of 2025, according to S&P Global Market Intelligence data.

Seeking Alpha • May 7, 2026

ETFs Offer Gateway to Once-Inaccessible Private Markets

Lately it seems as if most roads lead to the democratization of private markets.

ETF Trends • Aug 18, 2025

3 Thoughts on Retail Advisors & Private Equity for 2H

Retail investing has long proved a tantalizing prospect for private equity players. Traditionally a space for limited partners with huge asset pools, like family offices, endowments, pension programs, high net worth individuals (HWNI) and more, private equity funds saw their doors open just slightly more to retail investors in May.

ETF Trends • Aug 5, 2025

PSP: Stay Away From This ETF, Strong Sell

PSP is a strong sell due to persistent underperformance versus SPY and its high expense ratio, eroding any potential alpha. Private equity exposure can be achieved more efficiently by directly holding top players like Blackstone, KKR, and Ares, avoiding ETF fees. PSP's asset mix dilutes returns by combining best-in-class managers with weaker players, resulting in subpar performance.

Seeking Alpha • Jul 7, 2025

PSP: An Efficient Avenue to Private Equity Access

The investing landscape is littered with vehicles that have auras of exclusivity. It feels as though it's off-limits to ordinary investors.

ETF Trends • May 7, 2025